Let's see if analysts think that investors should be snapping up this quality company's shares. The post The CSL share price ...

Approvals in the EU and US would be good news for CSL and its shares. That's because Goldman sees potential for garadacimab ...

Vandyck, Michael Wayne, and Henry Jennings each boldly nominate the one ASX stock they believe will hit $500 first.

Goldman Sachs analyst Davinthra Thillainathan maintained a Buy rating on CSL (CMXHF – Research Report) today and set a price target of ...

The CSL Ltd (ASX: CSL) share price underperformed the S&P/ASX 200 Index (ASX: XJO) in 2024. While the benchmark index gained around 7.5% in the year just past, shares in the ASX 200 biotech stock ...

CSL Finance Limited is an India-based non-banking financial company (NBFC). The Company is engaged in the business of secured and unsecured lending to small and medium-sized businesses, including ...

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with BioMarin Pharmaceutical (BMRN) and CSL Limited Sponsored ADR (CSLLY). But which of these two stocks presents ...

SCOTTSDALE, Ariz., November 01, 2024--The Board of Directors of Carlisle Companies Incorporated (NYSE:CSL) has declared a dividend of $1.00 per share, payable on December 2, 2024, to shareholders ...

Key Insights CSL's estimated fair value is AU$408 based on 2 Stage Free Cash Flow to Equity CSL is estimated to be ...

Goldman Sachs analyst Davin Thillainathan initiated coverage of CSL (CSLLY) with a Buy rating and A$325.40 price target The firm believes the ...

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.